Congestive heart failure ... EDV can then be used to calculate the ejection fraction (EF), the value of which describes the pumping efficiency of the heart. Normally, the ejection fraction should be ...

Adverse left ventricular remodeling is a significant cardiovascular predictor for patients with coronary artery disease and preserved left ventricular ejection fraction ... of structural heart disease ...

This study explores a new non-invasive multimodality method of measuring ESWS, combining echocardiographic and MRI images. ESWS and ESWS-corrected EF as a marker of contractility ... function and the ...

Mean corpuscular hemoglobin concentration (MCHC) is a blood test that calculates the average concentration of hemoglobin in red blood cells in relation to their total volume. Hemoglobin is an ...

For patients with heart failure with preserved ejection fraction (HFpEF), endovascular treatment (EVT) improves left ...

In addition to improving heart failure symptoms, finerenone reduced the onset of new type 2 diabetes in patients with mildly ...

LONDON — The benefit of mineralocorticoid receptor antagonists (MRAs) for the treatment of patients with heart failure and mildly reduced or preserved ejection fraction has finally been ...

Data regarding the efficacy and safety of the nonsteroidal mineralocorticoid receptor antagonist finerenone in patients with heart failure and mildly reduced or preserved ejection fraction are needed.

The medication, finerenone, could be an effective therapy in people with heart failure who have mildly reduced or preserved ejection fraction, suggests the study, published Sunday in the New Engla ...